Rosenbaum Jay D. Eli Lilly & CO Transaction History

Rosenbaum Jay D.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $186,486 - $257,099	429 New	429 $230,000
Q2 2019 Aug 01, 2019	SELL	$110.79 - $129.32 $177,264 - $206,912	-1,600 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$111.31 - $131.02 $178,096 - $209,632	1,600 New	1,600 $208,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Rosenbaum Jay D., based on Form 13F filings with the SEC.

Stay updated on Rosenbaum Jay D. with notifications on news.